By joining Virttu REPLICATE, researchers gain access to latest data and insights into the use of oncoviruses and access to SEPREHVIR[TM] - an engineered herpes simplex virus which is highly lytic, has a broad tissue tropism, replicates selectively in cancer cells and with safety demonstrated in man.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.